Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

<b>Background:</b> To investigate whole-body contrast-enhanced CT and hepatobiliary contrast liver MRI for the detection of extrahepatic disease (EHD) in hepatocellular carcinoma (HCC) and to quantify the impact of EHD on therapy decision. <b>Methods:</b> In this post-hoc ana...

Full description

Bibliographic Details
Main Authors: Thomas Geyer, Philipp M. Kazmierczak, Ingo G. Steffen, Peter Malfertheiner, Bora Peynircioglu, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Maciej Pech, Christian Sengel, Irene Bargellini, Roberto Iezzi, Alberto Benito, Christoph J. Zech, Antonio Gasbarrini, Kerstin Schütte, Jens Ricke, Max Seidensticker
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Biomedicines
Subjects:
hepatocellular carcinoma
extrahepatic disease
liver MRI
patient management
therapeutic decision-making
Online Access:https://www.mdpi.com/2227-9059/10/5/1156

Similar Items

Similar Items